The ENHANCE Study: an unusual publication of trial data raises questions beyond ezetimibe.
about
Quality and efficiency of statin prescribing across countries with a special focus on South Africa: findings and future implications.Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.
P2860
The ENHANCE Study: an unusual publication of trial data raises questions beyond ezetimibe.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@en
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@nl
type
label
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@en
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@nl
prefLabel
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@en
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@nl
P2860
P1476
The ENHANCE Study: an unusual ...... es questions beyond ezetimibe.
@en
P2093
Keith Suckling
P2860
P304
P356
10.1517/14656566.9.7.1067
P407
P577
2008-05-01T00:00:00Z